Feb 19 2020
FDA Authorizes First Test to Aid in Newborn Screening for Duchenne Muscular Dystrophy
Earlier this month, the U.S. Food and Drug Administration authorized the marketing of the first test to aid in newborn screening for Duchenne muscular dystrophy, a rare genetic disorder characterized by progressive muscle loss. To read more, click here.
Comments Off on FDA Authorizes First Test to Aid in Newborn Screening for Duchenne Muscular Dystrophy